Author Question: What factor generally determines which co-branding method is chosen by a franchisor? a. expertise ... (Read 107 times)

jwb375

  • Hero Member
  • *****
  • Posts: 540
What factor generally determines which co-branding method is chosen by a franchisor?
 a. expertise
  b. personal preference
  c. profit potential
  d. none of these is a determining factor.

Question 2

Service performances are not considered to be multifaceted phenomena.
 
 Indicate whether the statement is true or false



Briannahope

  • Sr. Member
  • ****
  • Posts: 364
Answer to Question 1

A. A co-branding relationship involving franchisors may develop through a variety of methods. The underlying motivation to engage in partnering activities is often a result of a firm's evaluation of its resources and expertise. Exhibit 7-3 presents a two by two matrix of resources by expertise and their resulting co-branding methods.

Answer to Question 2

F



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The cure for trichomoniasis is easy as long as the patient does not drink alcoholic beverages for 24 hours. Just a single dose of medication is needed to rid the body of the disease. However, without proper precautions, an individual may contract the disease repeatedly. In fact, most people develop trichomoniasis again within three months of their last treatment.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library